Improving the lives of persons diagnosed with pancreatic cancer by innovative research and clinical care.
Over the past several years, there has been a tremendous explosion in research activity around pancreatic cancer at UC San Diego, Sanford-Burnham Medical Research Institute and the Salk Institute. The C3- Pancreatic Cancer Research Group will build on the C3 collaborative agreement between UC San Diego Moores Cancer Center and the NCI basic cancer centers at Sanford-Burnham Medical Research Institute and the Salk Institute for Biological Studies.
Our mission is to unite scientists and clinicians committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.
We seek to stimulate team science and translational research collaborations in the pancreatic cancer space and:
- More closely align basic and clinician researchers working in pancreatic cancer
- Accelerate research and translation across campuses
- Facilitate sharing of resources such as mouse models, cell lines, and tool compounds
- Enable competitive large grant submissions and unique industrial collaborations
- Attract new minds to the field from other research areas
Team Leaders
Andrew Lowy, MD
UC San Diego
Cosimo Commiso, PhD
Sanford Burnham
Pamela Itkin-Ansari
Sanford Burnham
Dannielle Engle
Salk Institute
C3 PCRG Events
Monthly seminars are open to those from both academia and industry, interested in connecting with other investigators.
Program Contact:
Shirley Sarno
Regional Therapies Program ManagerPhone 858-246-0966